Tyvaso ratings & reviews

Treprostinil
Company: UTC
Brand: Tyvaso
+1 more
Tyvaso, Remodulin
Drug class: Cardiovascular System
+3 more
Cardiovascular System, Cardiac Therapy, Pulmonary Hypertension (PAH) Agents, Prostacyclin Analogs/Receptor Agonists for PAH
Overall rating
3.4
full star full star full star empty star empty star
Ranked #9
Physician ratings
  • Efficacy: effective for its intended use
  • Safety: safe to use in humans
  • Tolerability: low drug side effects
  • Accessibility: insurance/payer coverage, cost, affordability,formulary coverage, availability in your hospital or practice setting
  • Adherence: patient compliance with treatment
Efficacy
3.6/5
Safety
3.6/5
Tolerability
3.4/5
Accessibility
2.8/5
Adherence
3.4/5

Sermo AI Overview

  • Tyvaso displays variable efficacy in treating conditions such as pulmonary hypertension and interstitial lung disease, with mixed reviews from physicians. While some patients respond positively, others do not benefit significantly from the treatment.
  • Access to Tyvaso is frequently criticized due to its high cost, making it difficult for some patients to obtain despite recommendations from physicians, which could hinder treatment adherence for those who experience significant side effects.
  • Was this summary helpful?
Based on insights from Sermo’s triple verified physicians

Description

Tyvaso is a sterile inhalation solution that contains the active ingredient treprostinil, which acts as a prostacyclin mimetic. It is administered through oral inhalation using the Tyvaso Inhalation System. The solution is supplied in 2.9 mL ampules with each ampule containing 1.74 mg of treprostinil and key inactive ingredients such as sodium chloride, sodium citrate dihydrate, and sodium hydroxide.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is for inhalation using a nebulizer. Nebulizers make a liquid into an aerosol that you breathe in through your mouth or your mouth and nose and into your lungs. Only use with the Tyvaso Inhalation System. Do not mix this medication with other medications in the nebulizer. Take it as directed on the prescription label. Do not use it more often than directed. Keep taking it unless your care team tells you to stop.

This medication comes with INSTRUCTIONS FOR USE. Ask your pharmacist for directions on how to use this medication. Read the information carefully. Talk to your pharmacist or care team if you have questions.

Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

If you miss a dose, take it as soon as you can. If it is almost time for your next dose, take only that dose. Do not take double or extra doses.

Where should I keep my medication?

Keep out of the reach of children and pets.

Store ampules in the unopened foil pouch at 20 to 25 degrees C (68 to 77 degrees F). Keep unopened ampules in the foil pouch. Once the foil pouch is open, use the ampules inside within 7 days. Protect from light. Do not open an ampule until you are ready to use it. Get rid of any unused medication after the expiration date.

Once the medication is put into the nebulizer, it should stay in the device for no more than 24 hours. Any unused medication in the device should be thrown away at the end of the day.

To get rid of medications that are no longer needed or have expired:

  • Take the medication to a medication take-back program. Check with your pharmacy or law enforcement to find a location.
  • If you cannot return the medication, ask your pharmacist or care team how to get rid of this medication safely.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Bleeding—bloody or black, tar-like stools, vomiting blood or brown material that looks like coffee grounds, red or dark brown urine, small red or purple spots on skin, unusual bruising or bleeding
  • Low blood pressure—dizziness, feeling faint or lightheaded, blurry vision
  • Wheezing or trouble breathing

Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):

  • Cough
  • Dizziness
  • Facial flushing, redness
  • Headache
  • Irritation inside the nose or throat
  • Nausea
  • Sore throat

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

  • Liver disease
  • Low blood pressure
  • Lung or breathing disease (asthma, COPD)
  • Wheezing (trouble breathing with loud or whistling sounds)
  • An unusual or allergic reaction to treprostinil, other medications, foods, dyes, or preservatives
  • Pregnant or trying to get pregnant
  • Breastfeeding

What may interact with this medication?

  • Certain medications for high blood pressure or heart disease
  • Gemfibrozil
  • Rifampin

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse.

This medication may increase your risk to bruise or bleed. Call your care team if you notice any unusual bleeding.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

  3. Authorized User acknowledges and agrees that the Elsevier Products are designed for and are intended to be used by those residing in the United States, and that the information contained in the Elsevier Products does not comply with any laws or practices outside of the United States. You assume all responsibilities, duties, and obligations for any treatment, decision, or advice made or given to third parties as a result of the use or application of the Elsevier Products outside of the United States, and Sermo, Elsevier and its affiliates, subsidiaries, agents and suppliers will incur no liability for any use or application of the Products by Authorized Users outside of the United States.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence